Holding vaccines at 2–8°C from central depot to remote clinic across a conflict-zone supply route
The "cold chain" is the unbroken sequence of refrigerated storage and transport that keeps a vaccine within its licensed temperature range from the moment it leaves the manufacturer to the moment it is injected. Most Expanded Programme on Immunization (EPI) vaccines are held at 2–8°C; a smaller set of live-attenuated products historically required deep-freeze storage at −15 to −25°C. Break the chain anywhere along the route and potency can be lost — silently, with no visible sign.
Most inactivated and adjuvanted vaccines — diphtheria-tetanus-pertussis (DTP), hepatitis B, pentavalent, inactivated polio vaccine (IPV) — are formulated to remain stable at 2–8°C. This narrow band balances two failure modes: heat degrades the antigen or adjuvant over time, while freezing can destroy it almost instantly.
A smaller category — live oral polio vaccine (OPV) and some older lyophilized measles formulations — has historically required deep-freeze storage at −15 to −25°C for long-term stability, because the live virus is far more heat-labile than an inactivated antigen. Newer thermostable formulations have narrowed this gap, but deep-freeze equipment remains part of many national EPI cold chains.
Critically, aluminum-adjuvanted vaccines (DTP, HepB, pentavalent, IPV) are also extremely freeze-sensitive: a few hours below 0°C causes the adjuvant to aggregate irreversibly, destroying potency even though the vial looks completely normal afterward.
Freeze damage is frequently a bigger real-world problem than heat exposure. Cold-chain monitoring audits in multiple countries have found that a substantial share of vaccine shipments experience freezing temperatures somewhere between depot and clinic — damage that is permanent and invisible without a freeze indicator.
Central and regional depots typically hold stock in walk-in cold rooms (WICRs) — insulated, refrigerated rooms large enough to store pallets of vaccine, maintained at 2–8°C with redundant compressors and backup generator power.
Equipment used anywhere in the chain — cold rooms, refrigerators, cold boxes, vaccine carriers, ice packs — is vetted under WHO's Performance, Quality and Safety (PQS) prequalification programme, which sets minimum standards for hold-over time, temperature stability, and performance at ambient extremes (testing typically simulates 43°C ambient conditions).
Depots log temperature continuously with electronic data loggers (commonly recording every 30 minutes), with audible/visual alarms if the room drifts out of range — the first line of defense long before a shipment ever reaches a conflict-affected road.
In regions where grid power is intermittent or absent — much of rural Sub-Saharan Africa, and conflict-affected areas of Yemen, Syria, and Afghanistan — WHO PQS-listed solar direct-drive (SDD) refrigerators have become the backbone of peripheral cold chain. SDD units run compressors directly from solar panels without a battery bank, using highly insulated ice-lined refrigerator (ILR) cabinets with phase-change ice banks that buffer the payload against several days of cloudy weather or zero sun.
Gavi's Cold Chain Equipment Optimisation Platform (CCEOP), launched in 2017, has co-financed solar refrigeration for tens of thousands of health facilities across the world's poorest and most fragile settings, directly targeting the "last mile" facilities that grid-dependent refrigeration could never reliably reach.
| Product | Indication | Trial Design | Key Result |
|---|---|---|---|
| OPV (oral polio, live) | −15 to −25°C (deep-freeze) | Very high — most heat-sensitive EPI vaccine | Must be frozen; not freeze-sensitive |
| Measles / MMR (lyophilized) | 2–8°C; −15 to −25°C for long-term stock | High — live virus degrades quickly above 8°C | Diluent must never freeze |
| DTP / Pentavalent / HepB | 2–8°C only | Moderate | Very high — aluminum adjuvant destroyed by freezing |
| IPV (inactivated polio) | 2–8°C only | Moderate–high | High — freezing damages antigen |
| mRNA COVID-19 | −70°C ultra-cold or −20°C; days at 2–8°C once thawed | Extreme at room temperature | Not applicable — stored frozen |
| Yellow fever (live, lyophilized) | 2–8°C, reconstitute just before use | High once reconstituted — use within session | Moderate |
Once vaccines leave a powered refrigerator, they depend entirely on passive cooling: insulated boxes and ice packs with a fixed, finite thermal budget. Unlike an electric refrigerator, a cold box cannot be topped up mid-journey — every hour of transit, every delay, and every detour draws down against a cooling reserve that started counting the moment the lid closed.
Two classes of passive cooling device move vaccines once they leave powered storage:
• Cold boxes: larger, heavily insulated containers used for bulk transport between depots and district stores. WHO PQS-listed cold boxes are rated to hold 2–8°C for 2–4 days at 43°C ambient temperature, depending on model.
• Vaccine carriers: smaller, backpack-portable insulated boxes used for the final leg — a health worker's trip from a district store to an outreach post or remote clinic. Typical hold-over time is roughly 24–48 hours, far shorter than a cold box, because the insulation volume is smaller.
Both devices are entirely passive: once packed, they contain no active refrigeration. Their entire performance depends on the quality of the ice packs and how well the box was packed and sealed.
A critical, frequently overlooked WHO EPI protocol step is "conditioning" ice packs before packing freeze-sensitive vaccines (DTP, HepB, pentavalent, IPV): letting frozen ice packs sit at room temperature for roughly 2–3 hours until they reach 0°C and begin to sweat, rather than packing them straight from a deep-freezer.
Unconditioned, still-frozen ice packs placed directly against freeze-sensitive vials are one of the most common causes of freeze damage in the field — damage that is permanent and invisible on inspection. Only vaccines that must remain frozen (like OPV) are packed with fully frozen ice packs.
In 2013–2015, negotiated humanitarian pauses known as "Days of Tranquility" — a term first used during El Salvador's civil war in 1985 — allowed WHO/UNICEF vaccination teams brief, agreed windows of safe passage to reach children across besieged areas of Syria during the country's polio outbreak response.
Shipments increasingly travel with electronic temperature data loggers (compact devices such as Fridge-tag or LogTag) that record temperature at short fixed intervals throughout the journey and can trigger an audible alarm the moment the load drifts outside 2–8°C.
In conflict-affected corridors, some humanitarian cold chains now pair these with store-and-forward IoT sensors that upload a full temperature history once the vehicle regains cellular signal — useful because live tracking is often impossible in contested or communications-denied areas for hours at a time.
A passive cold box does not care whether a vehicle is moving. Its cooling budget depletes on a clock, not an odometer — so an hour spent negotiating at a checkpoint costs exactly as much thermal reserve as an hour of highway driving. In active conflict zones, checkpoint waits are frequent, unpredictable, and can consume the entire margin built into the trip plan.
A Vaccine Vial Monitor is a small heat-sensitive label, developed by WHO and PATH, fixed to the vaccine vial cap or label. It contains an inner square of heat-sensitive material surrounded by a fixed-color reference ring. As the vaccine is exposed to cumulative heat, the inner square darkens irreversibly and progressively — faster at higher temperatures — until it matches or exceeds the color of the outer ring.
Four standard read points are used in the field: • Stage A — inner square lighter than the ring: use the vaccine • Stage B — inner square matches the ring more closely, but still lighter: use, but prioritize this vial soonest • Stage C — inner square equals the ring color: do not use • Stage D — inner square darker than the ring: discard
Because the reaction is a genuine time-temperature integration, a VVM effectively answers the one question a thermometer reading at a single moment cannot: how much cumulative heat has this specific vial actually experienced across its entire journey?
Unlike spoiled food, a vaccine that has lost potency to heat exposure shows no visible sign whatsoever — no smell, no color change, no cloudiness, no separation. A health worker looking at, or even opening, a compromised vial cannot tell by inspection that it has failed.
This is precisely why the VVM exists: it converts an invisible, cumulative physical process into a simple, field-readable color comparison that requires no equipment, no electricity, and no calculation — just a glance before the syringe is filled.
Because VVM status reflects a vial's actual cumulative heat history rather than a printed expiry date, WHO guidance gives the VVM reading priority over the labeled expiry date in the field — a vial can still be usable past its nominal date if the VVM shows Stage A or B, and must be discarded before its expiry date if the VVM shows Stage C or D.
In fragmented conflict zones such as Yemen and Afghanistan, a single route can cross checkpoints operated by different armed groups or authorities, each potentially requiring its own separate negotiation for safe passage. Delays are rarely predictable in advance, and a route planned around a 6-hour transit time can stretch to 12 or more hours with no way to replenish the ice pack budget mid-journey.
Field teams compensate by over-provisioning ice packs relative to the planned transit time, but every additional hour of unplanned delay still erodes that margin — which is exactly what this stage's temperature gauge is modeling.
Active fighting, damaged infrastructure, or a newly contested front line can close the direct road with no warning. Humanitarian convoys are then forced onto longer, often rougher detours — adding distance, time, and fuel consumption, all of which compound the cold-chain exposure risk that has already been accumulating since departure.
In Yemen, years of conflict and a fuel-import blockade repeatedly threatened the national EPI cold chain — not only by blocking roads, but by starving generator-backed refrigerators of the diesel needed to keep them running, forcing WHO and UNICEF to prioritize fuel deliveries to cold rooms alongside vaccine shipments themselves.
In Afghanistan, polio vaccination campaigns have depended on locally negotiated access agreements, sometimes community by community, with vaccinator teams occasionally facing direct attacks — reshaping route plans on short notice and forcing last-minute detours around contested districts.
In Syria, shifting front lines around Aleppo and Idlib repeatedly cut planned supply routes, requiring cold-chain convoys to reroute through longer, less secure roads or to pause shipments entirely until a corridor reopened.
To reduce the risk of a convoy being caught in crossfire or struck in error, UN OCHA and partner agencies operate humanitarian notification systems: planned movements, including vaccine cold-chain convoys, are shared in advance with all parties to a conflict in an attempt to secure safe passage.
This deconfliction process itself adds planning time before a shipment can even depart, and a denied or delayed notification can force a route change on short notice — precisely the kind of disruption this stage represents.
Because any single route can be cut without warning, resilient cold chains in conflict settings do not rely on one central depot supplying long routes to every clinic. Instead, agencies pre-position buffer stock across multiple regional depots and push solar-powered ice-lined refrigeration further toward the periphery — shortening the distance any single shipment has to travel through contested territory, and reducing how much the system depends on any one road staying open.
Arrival at the clinic is not the end of the cold chain — it is the final checkpoint. Before any dose is drawn into a syringe, a trained health worker reads the Vaccine Vial Monitor and cross-checks the shipment's temperature log. Batches that ran too hot for too long, or that were exposed to freezing, are set aside as unusable, regardless of how the journey looked from the outside.
A trained vaccinator compares the VVM's inner square directly against its reference ring under good light: if the square is still lighter than the ring, the vial is used; if it has darkened to match or exceed the ring, the entire vial is discarded — no exceptions, regardless of how many doses remain inside.
Alongside the VVM, the accompanying data logger record or paper temperature log is reviewed for any recorded excursions above 8°C or below 0°C during transit. For freeze-sensitive vaccines, a separate freeze indicator (such as a Freeze Watch or Freeze Tag card, which permanently changes color on exposure to freezing) is checked as well, since a VVM alone does not detect cold damage.
Since 2016, the drone logistics company Zipline has operated beyond-visual-line-of-sight delivery networks in Rwanda, later expanding to Ghana, flying blood products and vaccines directly to rural health facilities in a fraction of the time a road trip would take — particularly valuable when roads are damaged, flooded, or insecure.
In 2018, UNICEF ran one of the first drone vaccine delivery pilots to remote islands of Vanuatu, successfully delivering vaccines to communities otherwise reachable only by boat over difficult seas — a proof of concept for reaching populations that conventional cold-chain logistics struggle to serve at all, conflict zones included.
A vaccine that has silently lost potency to heat exposure looks, smells, and behaves exactly like a fully effective one — which is why the few seconds spent reading a VVM before administering a dose is the single most important quality check in the entire cold chain.
Every discard event and every recorded excursion is meant to feed back into the system, not just be logged and forgotten. WHO's Effective Vaccine Management (EVM) assessment tool is used by national EPI programs to score cold-chain performance end-to-end — storage, transport, and last-mile handling — and to identify which links in the chain (equipment, training, route planning) most need investment.
In a conflict zone, this feedback loop is harder to sustain — reporting infrastructure is itself disrupted — but the discarded batch at the end of this simulation represents exactly the kind of data point that, aggregated over many shipments, tells program planners where the chain is breaking and why.